SGMT Stock Analysis: Buy, Sell, or Hold?
SGMT - Sagimet Biosciences Inc. Series A Common Stock
$6.83
-0.23 (-3.26%)
▼
5d:
+8.41%
30d:
-3.67%
90d:
+47.52%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When SGMT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SGMT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: SGMT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: SGMT is currently trading at $6.83, which is considered slightly low relative to its 30-day fair value range of $6.51 to $7.30.
Technical Outlook: Technically, SGMT is in a uptrend. Immediate support is located at $6.24, while resistance sits at $7.34. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: SGMT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.20 (+271.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGMT is in a uptrend. Immediate support is located at $6.24, while resistance sits at $7.34. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: SGMT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.20 (+271.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$6.51 -
$7.30
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 271.1% below Wall St target ($26.20)
Trading Range Analysis
30-Day Trading Range
$6.51 -
$7.30
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$6.24
Resistance Level
$7.34
Current Trend
Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.38
Wall Street Target
$26.20
(+271.1%)
Share & Embed Analysis
Last updated: June 24, 2026 3:47 PM ET
Data refreshes hourly during market hours. Next update: 4:47 PM
Data refreshes hourly during market hours. Next update: 4:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGMT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
David Happel
SELL
12101 shares
2026-02-10
Thierry Chauche
SELL
1312 shares
2026-02-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 60 BUY |
